BridgeBio Pharma, Inc. (BBIO)

77.36 USD-1.20%
Gurus hold2popularity #498 of 1921
Net buying (quarter)−$144.1M0 buying · 2 selling
Market Cap$15.07B
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossEPS -3.04

BridgeBio Pharma, Inc. (BBIO) is not among the 30 most-held stocks of the tracked superinvestor set. Price 77.36 USD; market cap $15.07B.

Guru Ownership

Popularity rank#498 of 1,921 securities
gurus hold it2
Net activity this quarter−$144.1M

Guru count: the consensus-panel funds (wide books such as Citadel or Renaissance excluded) holding the stock at quarter end; the header and the history table use the same definition.

What changed this quarter
$0.00 · 0 new buys · 0 added $144.1M · 2 reduced · 0 sold out0 net buyers · 2 net sellers
Top 5 by conviction
Viking Global Investors2.1%Reduced -16.0%
Polen Capital Management0.0%Reduced -91.3%
Top 5 by value
Viking Global Investors$741.0MReduced -16.0%
Polen Capital Management$298.1KReduced -91.3%
Ownership by quarter · 72 funds with stored history
Report forgurus hold itTotal ValueAvg Weight
2019-06-301$718.0M3.2%
2019-09-301$571.6M3.0%
2019-12-311$933.1M4.4%
2020-03-311$772.0M4.0%
2020-06-301$868.1M3.8%
2020-09-301$998.8M3.6%
2020-12-311$1.89B5.2%
2021-03-311$1.64B4.9%
2021-06-301$1.62B4.9%
2021-09-301$1.25B3.4%
2021-12-311$444.0M1.3%
2022-03-311$270.2M1.1%
2022-06-301$241.7M1.1%
2022-09-301$264.6M1.2%
2022-12-311$202.9M1.0%
2023-03-311$441.4M2.1%
2023-06-301$457.9M1.9%
2023-09-301$662.4M2.7%
2023-12-311$1.01B3.7%
2024-03-311$776.7M2.9%
2024-06-301$636.3M2.4%
2024-09-301$639.6M2.3%
2024-12-311$689.3M2.2%
2025-03-312$777.6M1.5%
2025-06-302$802.8M1.2%
2025-09-302$831.8M1.1%
2025-12-312$1.10B1.5%
2026-03-312$882.8M1.2%
2026-06-302$741.3M1.1%

Price & valuation

Prev Close78.3
Open78.76
Day Range76.95 – 79.13
52 Week Range—
Volume—
Avg Volume (3M)—
Market Cap$15.07BSEC 10-Q, 10/22/2026
BetaVolatility vs the market. Above 1: swings harder than the index.0.872 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossSEC 10-Q, 09/30/2026
EPS (TTM)Annual net profit per share.-3.04SEC 10-Q, 09/30/2026
Dividend YieldAnnual dividend over share price.—

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Frequently Asked Questions

Which superinvestors own BBIO?

BridgeBio Pharma, Inc. (BBIO) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on BBIO bullish or bearish?

BBIO is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.